Jaguar Health, Inc. (JAGX) Corporate Subsidiaries
Jaguar Health, Inc. (JAGX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: JAGX
CIK: 1585608
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RBSM LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerSAM BERDE
Audit LocationLARKSPUR, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-08 | 2026-11-06 | DEF 14A | 0001193125-26-417938 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-30 | 8-K | 0001193125-26-413233 | View SEC Doc Filr Page |
| PRER14A | 2026-09-29 | — | PRER14A | 0001193125-26-407517 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001193125-26-403356 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-23 | 8-K | 0001193125-26-401239 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-24 | — | SCHEDULE 13G/A Filing | 0001185185-26-004289 | View SEC Doc Filr Page |
| 424B5 | 2026-09-24 | — | 424B5 | 0001193125-26-400348 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-23 | 8-K | 0001193125-26-400087 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-15 | 8-K | 0001193125-26-396752 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-18 | 2026-10-23 | PRE 14A | 0001193125-26-395715 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-11 | 8-K | 0001193125-26-391682 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-14 | 8-K | 0001193125-26-391415 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-04 | 8-K | 0001193125-26-383673 | View SEC Doc Filr Page |
| 424B5 | 2026-09-03 | — | 424B5 | 0001193125-26-381113 | View SEC Doc Filr Page |
| 424B3 | 2026-08-21 | — | 424B3 | 0001193125-26-360939 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001193125-26-356915 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001193125-26-356570 | View SEC Doc Filr Page |
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002662 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001193125-26-352657 | View SEC Doc Filr Page |
| POS AM | 2026-08-11 | — | POS AM | 0001193125-26-343471 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-03 | 2026-09-04 | DEF 14A | 0001193125-26-330694 | View SEC Doc Filr Page |
| 424B3 | 2026-07-27 | — | 424B3 | 0001193125-26-316920 | View SEC Doc Filr Page |
| 424B3 | 2026-07-27 | — | 424B3 | 0001193125-26-316918 | View SEC Doc Filr Page |
| EFFECT | 2026-07-24 | — | EFFECT Filing | 9999999995-26-002447 | View SEC Doc Filr Page |
| EFFECT | 2026-07-24 | — | EFFECT Filing | 9999999995-26-002446 | View SEC Doc Filr Page |